ArticleFrontiers in oncology2021

Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer.

Zhao Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.